Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call presents a mixed picture: strong core earnings growth and capital ratios indicate financial health, but declining revenue and net income raise concerns. The Q&A reveals increased expenses due to growth and tax planning, with management's vague responses on future ROE and tax rates. While shareholder returns are positive, the lack of clarity on future guidance tempers optimism, leading to a neutral sentiment.
Core earnings to shareholders (Full Year 2025) $142 million, up 57% year-over-year. This increase was attributed to positive emergence from short-term and long-term insurance portfolios, as well as operational improvements across the portfolio.
Core return on shareholders' equity (Full Year 2025) 14.2%, achieving the medium-term target a year ahead of schedule. This was supported by $15 million of positive emergence from insurance portfolios and improved debt cost of funding.
Revenue (Full Year 2025) $3 billion, compared to $3.1 billion in 2024. The slight decline was not elaborated upon in the transcript.
Net income to shareholders (Full Year 2025) $67 million, reflecting some volatility from market movements and foreign exchange.
Total comprehensive income to shareholders (Full Year 2025) $110 million, which allowed for a $77 million growth in shareholders' equity while returning over $40 million to shareholders through dividends and share buybacks.
Sagicor Canada Core earnings to shareholders (Full Year 2025) $103 million, up 19% year-over-year. This was due to improved net investment results and favorable insurance experience compared to unfavorable experience in 2024.
Sagicor Life USA Core earnings to shareholders (Full Year 2025) $41 million, up 2% year-over-year. Increased net investment results were offset by higher operating expenses to support business growth.
Sagicor Jamaica Core earnings to shareholders (Full Year 2025) $48 million, up year-over-year. This was driven by better margins on short-term business, favorable insurance experience, and improved net interest margin and fee revenue in the Commercial Banking segment.
Sagicor Life Core earnings to shareholders (Full Year 2025) $42 million, up 59% year-over-year. This increase was due to improved profitability in short-term business from price adjustments and favorable insurance experience.
Group LICAT ratio (Q4 2025) 136%, indicating strong capitalization.
Financial leverage ratio (Q4 2025) 26.9%, reflecting a stable financial position.
Book value per share (Full Year 2025) USD 7.65 or CAD 10.49, showing significant growth during the year.
Digital transformation in Canadian subsidiary: Completed migration of admin data for 750,000 in-force policies to a modern cloud-based system, enabling quicker product launches, better scalability, and cost improvements.
U.S. business asset growth: Increased assets by nearly $1 billion to $6.8 billion, with a clear path to $10 billion over the next three years.
Caribbean market consolidation: Announced merger of two Caribbean subsidiaries into a single publicly listed entity, enabling a full AI-driven digital transformation and strengthening market position.
Core earnings growth: Achieved record core earnings of $142 million, up 57% year-over-year, surpassing guidance.
Return on equity (ROE): Achieved a 14.2% core ROE, meeting medium-term targets a year ahead of schedule.
Digital transformation in Caribbean operations: Planned AI-driven transformation post-merger of Caribbean subsidiaries, expected to enhance operational efficiency and ROE growth.
Strategic focus on U.S. annuities: Maintained disciplined growth in U.S. annuities, surpassing $1 billion in new annuities in 2025, with plans for further expansion.
Market Volatility and Foreign Exchange: The company experienced a net loss to shareholders of $14 million in Q4 due to continuing volatility from market movements and foreign exchange. This indicates a risk of financial performance being adversely impacted by external market conditions.
Interest Rate Movements: Higher Canadian interest rates led to unfavorable market-related impacts, reducing net income to shareholders in the Canadian segment. Similarly, interest rate movements negatively impacted liabilities more than assets in the U.S. segment, causing market experience losses.
Increased Operating Expenses: The U.S. business faced increased operating expenses to support business growth, which slightly reduced core earnings to shareholders for the quarter.
Caribbean Subsidiary Merger Risks: The planned merger of Caribbean subsidiaries involves significant investment and operational transformation, including a full AI-driven digital transformation. This poses execution risks, potential delays, and cost overruns.
Regulatory and Structural Changes: The merger of Caribbean subsidiaries will alter the geography and proportions of earnings, potentially leading to transitional challenges and restructuring costs.
Investment Year Costs: 2026 is described as an investment year, with anticipated costs related to staffing, systems, and transformation initiatives, which may impact short-term profitability.
Core Earnings and ROE Projections: Sagicor projects core return on shareholders' equity (ROE) of approximately 14% in 2027 and 15% in 2028, with potential upside beyond these levels in subsequent years. The company expects core earnings to shareholders to run at $125 million to $130 million in 2026, with growth anticipated from compounding capital and strategic initiatives.
U.S. Annuities Business Growth: Sagicor plans to grow its U.S. annuities business assets from $7 billion to nearly $10 billion over a three-year planning cycle, with expectations of meaningful margin expansion. Investments in systems and executive hires are expected to support earnings growth proportional to asset growth.
Canadian Business Margin Expansion: The company aims to enhance financial margins in its Canadian business by applying lessons from its U.S. balance sheet management. This includes optimizing asset allocation to improve returns on the back book of policies.
Caribbean Digital Transformation: Sagicor plans a full AI-driven digital transformation of its newly combined Caribbean subsidiaries, expected to close in Q4 2026. This initiative aims to enhance operational efficiency and market position, contributing to ROE growth over the next 3-5 years.
Dividend Growth: Sagicor announced an 11% increase in its dividend payout to $0.075 per share, reflecting confidence in future earnings growth and a commitment to delivering growing dividends.
Dividend Increase: Sagicor announced an increase in its dividend payout to USD 0.075 per share or $0.30 annualized, representing an 11% increase over the previous year. This marks the third consecutive annual increase in March.
Dividend Payout Ratio: The company anticipates being at the lower end of its 30% to 40% core earnings target payout ratio, reflecting confidence in reinvesting earnings for growth while maintaining a growing dividend.
Share Buybacks: Sagicor returned over $40 million of capital to shareholders in 2025 through a combination of dividends and share buybacks.
The earnings call presents a mixed picture: strong core earnings growth and capital ratios indicate financial health, but declining revenue and net income raise concerns. The Q&A reveals increased expenses due to growth and tax planning, with management's vague responses on future ROE and tax rates. While shareholder returns are positive, the lack of clarity on future guidance tempers optimism, leading to a neutral sentiment.
The earnings call presents mixed signals: revenue growth and improved gross margins are positive, but the net loss and negative cash flow remain concerns. The lack of a clear shareholder return plan and the emphasis on forward-looking risks add uncertainty. The absence of a market cap limits the ability to predict small-cap volatility, but overall, the results suggest a neutral impact on stock price, likely within a -2% to 2% range.
The earnings call indicates strong revenue growth and strategic advancements, including securing a major enterprise client and advancing pipeline programs. While there are execution risks and market challenges, the consistent revenue growth and strategic partnerships suggest a positive outlook. The absence of negative sentiment in the Q&A further supports a positive sentiment. However, the lack of discussion on shareholder returns slightly tempers the outlook, preventing a strong positive rating.
The earnings call presents a positive outlook with a 54% revenue increase, improved gross margins, and reduced operating losses. The strategic focus on SaaS and data initiatives, alongside the strengthened cash position from the Netherlands divestiture, provides growth potential. The Q&A reveals cautious optimism with scalable operations and potential share price growth, despite some ambiguity about the Cayman structure and ATM facility. Overall, the financial performance and strategic initiatives suggest a positive stock price movement, likely in the 2% to 8% range.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.